Kolexia
Romieu Gilles Médecine générale
Romieu Gilles
Médecine générale
Institut régional du cancer de Montpellier
Lieu inconnu
132 Activités
65 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Tumeurs du sein Métastase tumorale Récidive tumorale locale Tumeurs du cerveau Tumeurs du sein triple-négatives Seconde tumeur primitive Cardiopathies Effets secondaires indésirables des médicaments Métastase lymphatique

Collaborateurs

Voir plus
Jacot William
Jacot William
Icm Montpellier, Montpellier, France
Bachelot Thomas
Bachelot Thomas
Centre Léon-Bérard, Lyon, France
Pivot Xavier
Pivot Xavier
Centre Paul Strauss, Strasbourg, France
Pierga Jean-Yves
Pierga Jean-Yves
Clcc Institut Curie, Paris, France

Industries

Voir plus
Amgen
1 collaboration(s)
Dernière en 2019
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Voir plus
CHACRY-1501: Risk of Infertility Related to Adjuvant Chemotherapy for Early Breast Cancer: Oocyte/Embryo Cryopreservation (CHACRY-1501)
Essai Clinique (Centre Oscar-Lambret)   13 février 2023
LBA11 Individual patient data meta-analysis of 5 non-inferiority RCTs of reduced duration single agent adjuvant trastuzumab in the treatment of HER2 positive early breast cancer
Abstract Book of the ESMO Congress 2021, 16 – 21 September 2021   01 septembre 2021
Changes in vitamin D and calcium metabolism markers in patients undergoing adjuvant chemotherapy for breast cancer.
BMC cancer   15 juillet 2021
Concomitant and Sequential Radiohormonotherapy in Adjuvant Breast Cancer: A Phase II Randomized Study to Compare Skin Late Toxicities of Concomitant Letrozole-Radiotherapy and Radiotherapy Followed by Letrozole as Adjuvant Therapy for Postmenopausal Women With Receptor (ER and/or PgR) Positive Tumors
Essai Clinique (Novartis)   01 juin 2021
VEGF-Related Germinal Polymorphisms May Identify a Subgroup of Breast Cancer Patients with Favorable Outcome under Bevacizumab-Based Therapy-A Message from COMET, a French Unicancer Multicentric Study.
Pharmaceuticals (Basel, Switzerland)   23 novembre 2020
Brief Hospital Supervision of Exercise and Diet During Adjuvant Breast Cancer Therapy Is Not Enough to Relieve Fatigue: A Multicenter Randomized Controlled Trial.
Nutrients   09 octobre 2020
Analysis of the StoRM cohort reveals physical activity to be associated with survival in metastatic breast cancer.
Scientific reports   01 juillet 2020
Safety and Immunogenicity Study of the New dHER2 Vaccine to Treat HER2-positive Metastatic Breast Cancer: A Multicenter, Open-label Phase I/II Trial of the Safety and Efficacy of the dHER2 Recombinant Protein Combined With Immunological Adjuvant AS15 in Patients With Metastatic Breast Cancer Overexpressing HER2/Neu
Essai Clinique (GSK)   26 décembre 2019
Author Correction: Landscape of somatic mutations in 560 breast cancer whole-genome sequences.
Nature   20 novembre 2019
Beverly1: Phase II Study Evaluating the Efficacy and Tolerance of Bevacizumab (Avastin) in HER2- Inflammatory Breast Cancer
Essai Clinique (Unicancer)   18 octobre 2019